Knowledge

Tigecycline

Source 📝

582: 559: 1110:. The antileukemic activity of tigecycline can be attributed to the inhibition of mitochondrial protein translation in eukaryotic cells. Leukemic cells have an increased dependence on mitochondrial function, causing a heightened sensitivity to tigecycline. Tigecycline has also shown anti-cancer properties against several other kinds of tumors, including non-small cell lung cancer, gastric cancer, hepatocellular carcinoma, and 1252:. In rats or rabbits, tigecycline crossed the placenta and was found in the fetal tissues, and is associated with slightly lower birth weights as well as slower bone ossification. Even though it was not considered teratogenic, tigecycline should be avoided unless benefits outweigh the risks. In addition, its use during childhood can cause yellow-grey-brown discoloration of the teeth and should not be used unless necessary. 31: 1336:. These antibiotics were the first new drugs of the tetracycline class to be reported since the discovery of minocycline in 1970. The glycylcyclines were found to be active against a broad spectrum of tetracycline susceptible and resistant Gram (-) and Gram (+) aerobic and anaerobic bacteria. This initial research resulted in numerous studies being done on the antibacterial activity of various 4058: 1328:
in 1970, but antibiotic resistance to the drug began growing in prevalence throughout the 70's and 80's. While the problem of antibiotic resistance was known to scientists during the 1980s, apathy led to little federal attention given to the emerging crisis. However, by the late 1980s the worldwide
1287:
in September 2010, for tigecycline regarding an increased risk of death compared to other appropriate treatment. As a result of increase in total death rate (cause is unknown) in individuals taking this drug, tigecycline is reserved for situations in which alternative treatment is not suitable. The
1270:
mortality in patients treated for hospital-acquired pneumonia, especially ventilator-associated pneumonia (a non-approved use), but also in patients with complicated skin and skin structure infections, complicated intra-abdominal infections and diabetic foot infection. Increased mortality was in
1379:
Studies have shown that tigecycline binds to the 70S ribosome with 5 fold and >100 fold greater affinity than minocycline and tetracycline, respectively . As previously mentioned, tigecycline still binds to the A site of the 30S ribosomal subunit, however the binding of the novel antibiotic
800:
Tigecycline is used to treat different kinds of bacterial infections, including complicated skin and structure infections, complicated intra-abdominal infections and community-acquired bacterial pneumonia. Tigecycline is a glycylcycline antibiotic that covers MRSA and Gram-negative organisms:
1303:: Since both tigecycline and warfarin bind to serum or plasma proteins, there is potential for protein-binding interactions, such that one drug will have more effect than the other. Although dose adjustment is not necessary, INR and prothrombin time should be monitored if given concurrently. 651: 1442:
it is approved in adults and in children from the age of eight years for the treatment of complicated skin and soft tissue infections (excluding diabetic foot infections) and complicated intra-abdominal infections in situations where other alternative antibiotics are not suitable.
1380:
involves substantial interactions with residues of helix H34 of that same subunit. These interactions are not observed in the binding of tetracycline. The findings indicate that tigecycline likely has a unique mechanism of action that prevents inhibition from ribosomal protection.
1340:, with extra focus being put on N,N-dimethylglycyl-amino derivatives, due to their reported potency. The aforementioned research culminated in a 1999 paper describing the discovery of a compound known as GAR-936, which would later be known as Tigecycline. 3088:
Hoffmann M, DeMaio W, Jordan RA, Talaat R, Harper D, Speth J, et al. (September 2007). "Metabolism, excretion, and pharmacokinetics of tigecycline, a first-in-class glycylcycline antibiotic, after intravenous infusion to healthy male subjects".
1761:
The selection and use of essential medicines: report of the WHO Expert Committee on Selection and Use of Essential Medicines, 2019 (including the 21st WHO Model List of Essential Medicines and the 7th WHO Model List of Essential Medicines for
1271:
comparison to other treatment of the same types of infections. The difference was not statistically significant for any type, but mortality was numerically greater for every infection type with Tigecycline treatment, and thus prompted a
693:
InChI=1S/C29H39N5O8/c1-28(2,3)31-11-17(35)32-15-10-16(33(4)5)13-8-12-9-14-21(34(6)7)24(38)20(27(30)41)26(40)29(14,42)25(39)18(12)23(37)19(13)22(15)36/h10,12,14,21,31,36,38-39,42H,8-9,11H2,1-7H3,(H2,30,41)(H,32,35)/t12-,14-,21-,29-/m0/s1
1423:
metabolite. Therefore, dose adjustments are needed for patients with severe hepatic impairment. More so, it is primarily eliminated unchanged in the feces and secondarily eliminated by the kidneys. No renal adjustments are necessary.
1126:
Tigecycline targets both Gram-positive and Gram-negative bacteria including a few key multi-drug resistant pathogens. The following represents MIC susceptibility data for a few medically significant bacterial pathogens.
1247:
Precaution is needed when taken in individuals with tetracycline hypersensitivity, pregnant women, and children. It has been found to cause fetal harm when administered during pregnancy and therefore is classified as
1437:
It is approved to treat complicated skin and soft tissue infections (cSSTI), complicated intra-abdominal infections (cIAI), and community-acquired bacterial pneumonia (CAP) in individuals 18 years and older. In the
2314:
Pournaras S, Koumaki V, Spanakis N, Gennimata V, Tsakris A (July 2016). "Current perspectives on tigecycline resistance in Enterobacteriaceae: susceptibility testing issues and mechanisms of resistance".
2728:
Sum PE, Lee VJ, Testa RT, Hlavka JJ, Ellestad GA, Bloom JD, et al. (January 1994). "Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines".
1070:
isolates have MICs <0.25 for tigecycline The European Society of Clinical Microbiology and Infection recommends tigecycline as a potential salvage therapy for severe and/or complicated or refractory
1239:
Rare adverse effects (<2%) include: swelling, pain, and irritation at injection site, anorexia, jaundice, hepatic dysfunction, pruritus, acute pancreatitis, and increased prothrombin time.
1186:
Tigecycline does not require dose adjustment for people with mild to moderate liver problems. However, in people with severe liver problems dosing should be decreased and closely monitored.
2476: 2443: 255: 3216: 2766:"N,N-dimethylglycyl-amido derivative of minocycline and 6-demethyl-6-desoxytetracycline, two new glycylcyclines highly effective against tetracycline-resistant gram-positive cocci" 1508: 1236:
Common side effects of tigecycline include nausea and vomiting. Nausea (26%) and vomiting (18%) tend to be mild or moderate and usually occur during the first two days of therapy.
1217:
spp. can be naturally resistant to tigecycline through the constant over-expression of such efflux pumps. In some Enterobacteriaceae species, mutations in ribosomal genes such as
986:
bacterial pathogens, many of which are resistant to existing antibiotics. Tigecycline successfully completed phase III trials in which it was at least equal to intravenous
2601:
Church RF, Schaub RE, Weiss MJ (March 1971). "Synthesis of 7-dimethylamino-6-demethyl-6-deoxytetracycline (minocycline) via 9-nitro-6-demethyl-6-deoxytetracycline".
1098:
and tumor metastasis. This is a feature not unique to minocycline, with many tetracyclines exhibiting non-antibiotic clinical benefits. Tigecycline has shown
3209: 2099:
Whiteman M, Halliwell B (January 1997). "Prevention of peroxynitrite-dependent tyrosine nitration and inactivation of alpha1-antiproteinase by antibiotics".
1733:
Executive summary: the selection and use of essential medicines 2019: report of the 22nd WHO Expert Committee on the selection and use of essential medicines
1403:, tigecycline has been found to improve minimal inhibitory concentrations against Gram-negative and Gram-positive organisms, when compared to tetracyclines. 1332:
In 1993, researchers in the same laboratories that first synthesized minocycline created a new generation of tetracycline antibacterial agents, known as the
210: 2862:
Sum PE, Petersen P (May 1999). "Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936".
1919:
Di Bella S, Nisii C, Petrosillo N (July 2015). "Is tigecycline a suitable option for Clostridium difficile infection? Evidence from the literature".
3202: 1613: 2444:"FDA Drug Safety Communication: Increased risk of death with Tygacil (tigecycline) compared to other antibiotics used to treat similar infections" 1086:
It is well established that tigecycline works as an effective antibiotic, however it may have other properties that are not yet fully understood.
1210: 2477:"FDA Drug Safety Communication: FDA warns of increased risk of death with IV antibacterial Tygacil (tigecycline) and approves new Boxed Warning" 1309:: Effectiveness of oral contraceptives are decreased with concurrent use due to reduction in the concentration levels of oral contraceptives. 995: 107: 2509:
Dixit D, Madduri RP, Sharma R (April 2014). "The role of tigecycline in the treatment of infections in light of the new black box warning".
1399:-dimethyglycylamido (DMG) moiety attached to the 9-position of tetracycline ring D. With structural modifications as a 9-DMG derivative of 665: 1015: 901: 818: 2815:"In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936)" 3040:
Nguyen F, Starosta AL, Arenz S, Sohmen D, Dönhöfer A, Wilson DN (May 2014). "Tetracycline antibiotics and resistance mechanisms".
3194: 780:(FDA) fast-track approval and was approved on 17 June 2005. It was approved for medical use in the European Union in April 2006. 1555: 3159:"Comparative in vitro activities of tigecycline (GAR-936) and other antimicrobial agents against Stenotrophomonas maltophilia" 4012: 784: 2636:
Macdonald H, Kelly RG, Allen ES, Noble JF, Kanegis LA (September 1973). "Pharmacokinetic studies on minocycline in man".
761:. As a tetracycline derivative antibiotic, its structural modifications has expanded its therapeutic activity to include 4093: 4083: 1059:
spp. The drug is licensed for the treatment of skin and soft tissue infections as well as intra-abdominal infections.
710: 158: 4088: 2005:
Garrido-Mesa N, Zarzuelo A, Gálvez J (January 2013). "What is behind the non-antibiotic properties of minocycline?".
1825: 1779: 1364:
with the A site of the ribosome. In addition, tigecycline has demonstrated bactericidal activity against isolates of
685: 4029: 2224:
Worasilchai N, Chindamporn A, Plongla R, Torvorapanit P, Manothummetha K, Chuleerarux N, et al. (March 2020).
1078:
Tigecycline can also be used in vulnerable populations such as immunocompromised patients or patients with cancer.
1038: 952:
Tigecycline may be used for treatment of community-acquired bacterial pneumonia caused by; penicillin susceptible
353: 240: 139: 2482: 2449: 1023: 922: 777: 577: 458: 2401:"Tigecycline-induced acute pancreatitis in a cystic fibrosis patient: A case report and literature review" 787:
in 2019. The World Health Organization classifies tigecycline as critically important for human medicine.
3229: 1353: 538: 527: 3717: 3621: 3272: 1209:
is often caused by genetic mutations leading to an up-regulation of bacterial efflux pumps, such as the
4048: 1233:
to the class of antibiotics. Gastrointestinal (GI) symptoms are the most common reported side effect.
3961: 1803: 1756: 1728: 1589: 1349: 1003: 2136:"Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia" 1329:
threat began to be treated more seriously, which led to the renewed funding of antibiotic research.
3480: 1384: 1366: 954: 827: 770: 739:
class drug that is administered intravenously. It was developed in response to the growing rate of
554: 3224: 3133:"Tygacil 50mg powder for solution for infusion - Summary of Product Characteristics (SPC) - (eMC)" 1959:
Kaewpoowat Q, Ostrosky-Zeichner L (February 2015). "Tigecycline : a critical safety review".
4017: 1461:
Tigilyn (Marketed by Real Value therapy pharmaceuticals company in Myanmar, Manufactured by Lyka)
1306: 1043: 938: 910: 833: 751: 728: 195: 97: 3363: 1372: 983: 979: 970: 960: 839: 766: 762: 507: 295: 1645:
Rose WE, Rybak MJ (August 2006). "Tigecycline: first of a new class of antimicrobial agents".
1509:"Prescription medicines: registration of new generic medicines and biosimilar medicines, 2017" 447: 4078: 1357: 1033: 896: 890: 851: 813: 745: 2134:
Skrtić M, Sriskanthadevan S, Jhas B, Gebbia M, Wang X, Wang Z, et al. (November 2011).
1584: 864:
Tigecycline is indicated for treatment of complicated intra-abdominal infections caused by;
382: 3670: 2053: 1325: 1249: 932: 916: 872: 866: 857: 845: 740: 732: 467: 315: 8: 3299: 2990:"Functional, biophysical, and structural bases for antibacterial activity of tigecycline" 2040:
Amin AR, Attur MG, Thakker GD, Patel PD, Vyas PR, Patel RN, et al. (November 1996).
1055: 373: 202: 2057: 1189:
Tigecycline does not require dose changes in people with poor kidney function or having
581: 558: 3114: 3065: 3014: 2989: 2926: 2710: 2661: 2583: 2534: 2254: 2225: 2160: 2135: 1984: 1901: 1670: 1256: 1202: 944: 884: 169: 2875: 2790: 2765: 2376: 2351: 2328: 1932: 1854: 1090:
has been shown to have anti-inflammatory and anti-apoptotic activities, inhibition of
3941: 3937: 3506: 3180: 3106: 3057: 3019: 2970: 2965: 2948: 2918: 2879: 2844: 2839: 2814: 2795: 2746: 2702: 2653: 2618: 2575: 2526: 2422: 2381: 2352:"Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects" 2332: 2259: 2206: 2165: 2116: 2081: 2076: 2041: 2022: 1976: 1936: 1893: 1821: 1785: 1775: 1710: 1662: 268: 131: 3069: 2714: 2665: 2538: 1988: 1905: 1674: 1313:
However, the mechanism behind these drug interactions have not been fully analyzed.
673:
CC(C)(C)NCC(=O)Nc1cc(c2C3C4(N(C)C)C(\O)=C(\C(N)=O)C(=O)4(O)C(/O)=C3/C(=O)c2c1O)N(C)C
407: 3989: 3933: 3561: 3170: 3118: 3098: 3049: 3009: 3001: 2960: 2930: 2910: 2871: 2834: 2826: 2785: 2777: 2738: 2692: 2645: 2610: 2587: 2565: 2518: 2412: 2371: 2363: 2324: 2278:"Tigecycline : Susceptibility and Minimum Inhibitory Concentration (MIC) Data" 2277: 2249: 2241: 2196: 2155: 2147: 2108: 2071: 2061: 2014: 1968: 1928: 1885: 1811: 1765: 1736: 1702: 1654: 1482: 1107: 878: 807: 757: 594: 287: 223: 117: 48: 3249: 3132: 2367: 2185:"Evaluating the efficacy of Tigecycline to target multiple cancer-types: A Review" 4062: 3980: 3975: 3687: 3556: 3551: 2522: 2042:"A novel mechanism of action of tetracyclines: effects on nitric oxide synthases" 1972: 1412: 1260: 305: 3245: 3241: 3237: 3233: 1876:
Scheinfeld N (2005). "Tigecycline: a review of a new glycylcycline antibiotic".
1693:
Kasbekar N (July 2006). "Tigecycline: a new glycylcycline antimicrobial agent".
4023: 3840: 3770: 3755: 3516: 3401: 3389: 3267: 2898: 2046:
Proceedings of the National Academy of Sciences of the United States of America
2018: 1439: 1388: 1361: 965: 2697: 2680: 2417: 2400: 2151: 2112: 1889: 4072: 3985: 3929: 3921: 3883: 3873: 3845: 3825: 3815: 3810: 3775: 3760: 3697: 3692: 3616: 3581: 3369: 3157:
Betriu C, Rodríguez-Avial I, Sánchez BA, Gómez M, Picazo JJ (November 2002).
2988:
Olson MW, Ruzin A, Feyfant E, Rush TS, O'Connell J, Bradford PA (June 2006).
2706: 2210: 2066: 1789: 1337: 1333: 1284: 1272: 1011: 1007: 736: 570: 22: 3969: 3965: 3893: 3830: 3800: 3765: 3735: 3571: 3546: 3531: 3521: 3511: 3485: 3426: 3374: 3321: 3294: 3284: 3184: 3110: 3102: 3061: 3023: 2974: 2922: 2883: 2848: 2579: 2530: 2426: 2385: 2336: 2304:
Tygacil . Philadelphia, PA: Wyeth Pharmaceuticals; 2005. Updated July 2010.
2263: 2230:
Susceptibility of Thai Pythium insidiosum Isolates to Antibacterial Agents"
2169: 2026: 1980: 1940: 1897: 1714: 1666: 1658: 1230: 1190: 1111: 1095: 805:
Tigecycline can treat complicated skin and structure infections caused by;
218: 3053: 2799: 2781: 2750: 2657: 2649: 2622: 2570: 2553: 2201: 2184: 2120: 2085: 3955: 3901: 3878: 3805: 3790: 3785: 3702: 3566: 3541: 3536: 3526: 3501: 3345: 3316: 3175: 3158: 3005: 2830: 2245: 2223: 1420: 1400: 1321: 1091: 1087: 1049: 978:
Tigecycline is given intravenously and has activity against a variety of
125: 2742: 2614: 1816: 1770: 1741: 427: 3951: 3911: 3906: 3855: 3835: 3820: 3795: 3750: 3745: 3679: 3650: 3630: 3450: 3445: 3436: 3431: 3416: 3411: 3359: 3311: 3225: 2949:"Tigecycline: in-vitro performance as a predictor of clinical efficacy" 2350:
Muralidharan G, Micalizzi M, Speth J, Raible D, Troy S (January 2005).
1706: 987: 627: 438: 2914: 2552:
Zimmerman JJ, Raible DG, Harper DM, Matschke K, Speth JL (July 2008).
3780: 3740: 3727: 3660: 3655: 3645: 3640: 3635: 3466: 3421: 3384: 3379: 3350: 3340: 3330: 1115: 1041:
values reported at 2 μg/mL) and multi-drug resistant strains of
991: 393: 334: 328: 111: 3865: 3335: 3306: 1556:"Tygacil- tigecycline injection, powder, lyophilized, for solution" 1300: 999: 487: 418: 153: 2813:
Petersen PJ, Jacobus NV, Weiss WJ, Sum PE, Testa RT (April 1999).
1296:
Tigecycline has been found to interact with medications, such as:
650: 3850: 3156: 2554:"Evaluation of a potential tigecycline-warfarin drug interaction" 2313: 2349: 1174:
Tigecycline generally has poor activity against most strains of
3947: 2133: 518: 338: 81: 30: 2551: 1114:. It also shows good activity against the causative agent of 641: 498: 2681:"The evolving response to antibiotic resistance (1945–2018)" 1810:(6th revision ed.). Geneva: World Health Organization. 1259:, with particular relevance to patients also diagnosed with 543: 1958: 1464:
TIGILITE (marketed in INDIA, Scutonix Lifesciences, Bombay)
1255:
More so, there are clinical reports of tigecycline-induced
1229:
As a tetracycline derivative, tigecycline exhibits similar
478: 72: 63: 57: 3087: 2004: 1221: have been found to cause resistance to tigecycline. 3607: 3258: 3039: 1802: 1755: 1727: 60: 2635: 1745:. WHO/MVP/EMP/IAU/2019.05. License: CC BY-NC-SA 3.0 IGO. 1356:. It exhibits bacteriostatic activity by binding to the 2812: 1918: 785:
World Health Organization's List of Essential Medicines
1808:
Critically important antimicrobials for human medicine
4046: 2987: 2896: 2039: 84: 75: 69: 51: 1550: 1360:
of bacteria and thereby blocking the interaction of
1014:
bacteria and anaerobes – including activity against
78: 54: 2899:"Tigecycline: A Novel Broad-Spectrum Antimicrobial" 2764:Goldstein FW, Kitzis MD, Acar JF (September 1994). 2763: 1548: 1546: 1544: 1542: 1540: 1538: 1536: 1534: 1532: 1530: 66: 2508: 1475: 2942: 2940: 2727: 2600: 2098: 4070: 2897:Slover CM, Rodvold KA, Danziger LH (June 2007). 1855:"TYGACIL U.S. Physician Prescribing Information" 1527: 1324:was a commonly used tetracycline synthesized in 406: 2471: 2469: 2438: 2436: 2182: 381: 2937: 1579: 1577: 996:complicated skin and skin structure infections 3210: 2398: 2317:International Journal of Antimicrobial Agents 1954: 1952: 1950: 1921:International Journal of Antimicrobial Agents 2890: 2864:Bioorganic & Medicinal Chemistry Letters 2466: 2433: 2392: 1912: 1640: 1638: 1636: 1634: 1483:"Tigecycline (Tygacil) Use During Pregnancy" 1201:Bacterial resistance towards tigecycline in 157: 2946: 2861: 1849: 1847: 1845: 1843: 1841: 1839: 1837: 1574: 1288:FDA updated the black box warning in 2013. 1181: 3678: 3217: 3203: 3083: 3081: 3079: 2183:Arora R, Jain S, Rahimi H (1 April 2018). 1947: 1875: 1695:American Journal of Health-System Pharmacy 1688: 1686: 1684: 580: 557: 446: 3174: 3163:The Journal of Antimicrobial Chemotherapy 3035: 3033: 3013: 2964: 2838: 2789: 2696: 2569: 2416: 2375: 2253: 2200: 2159: 2075: 2065: 1815: 1769: 1740: 1644: 1631: 466: 2678: 2504: 2502: 1834: 1692: 1196: 1081: 3076: 2511:Expert Review of Anti-Infective Therapy 1878:The Journal of Dermatological Treatment 1681: 553: 426: 130: 4071: 3030: 2638:Clinical Pharmacology and Therapeutics 2399:Hemphill MT, Jones KR (January 2016). 1721: 1513:Therapeutic Goods Administration (TGA) 1427: 1343: 1213:AcrAB. Some bacterial species such as 1121: 571: 274: 3198: 2994:Antimicrobial Agents and Chemotherapy 2819:Antimicrobial Agents and Chemotherapy 2770:Antimicrobial Agents and Chemotherapy 2499: 2356:Antimicrobial Agents and Chemotherapy 2234:Antimicrobial Agents and Chemotherapy 2000: 1998: 1764:. Geneva: World Health Organization. 1735:. Geneva: World Health Organization. 1006:. Tigecycline is active against many 1002:and cilastatian to treat complicated 526: 506: 262: 148: 116: 1458:Tigeplug (marketed by Biocon, India) 1291: 1278: 1062:"Tigecycline is also active against 795: 222: 2953:Clinical Microbiology and Infection 1792:. WHO technical report series;1021. 1411:Tigecycline is metabolized through 1406: 486: 397: 13: 1995: 1415:into glucuronide conjugates and a 14: 4105: 2329:10.1016/j.ijantimicag.2016.04.017 1933:10.1016/j.ijantimicag.2015.03.012 1594:(in Aragonese). 17 September 2018 1387:derivative within a class called 249: 180: 4056: 2966:10.1111/j.1469-0691.2006.01621.x 2947:Hawkey P, Finch R (April 2007). 2603:The Journal of Organic Chemistry 611: 605: 47: 29: 3150: 3125: 3091:Drug Metabolism and Disposition 2981: 2855: 2806: 2757: 2721: 2672: 2629: 2594: 2545: 2343: 2307: 2298: 2270: 2217: 2176: 2127: 2092: 2033: 1869: 1796: 1224: 790: 698:Key:FPZLLRFZJZRHSY-HJYUBDRYSA-N 364:--2-(tert-butylamino) acetamide 3718:transpeptidation/translocation 2731:Journal of Medicinal Chemistry 1749: 1606: 1501: 1446: 1242: 1162:(methicillin-resistant): 0.03 769:organisms, including those of 617: 599: 1: 2903:The Annals of Pharmacotherapy 2876:10.1016/S0960-894X(99)00216-4 2679:Podolsky SH (December 2018). 2368:10.1128/aac.49.1.220-229.2005 1961:Expert Opinion on Drug Safety 1468: 1047:. It has no activity against 2523:10.1586/14787210.2014.894882 2483:Food and Drug Administration 2450:Food and Drug Administration 1973:10.1517/14740338.2015.997206 1024:Stenotrophomonas maltophilia 923:Bacteroides thetaiotaomicron 778:Food and Drug Administration 723:, sold under the brand name 7: 1432: 1354:protein synthesis inhibitor 731:medication for a number of 10: 4110: 2405:Journal of Cystic Fibrosis 2019:10.1016/j.phrs.2012.10.006 1316: 1004:intra-abdominal infections 589:Chemical and physical data 4094:Drugs developed by Pfizer 4084:Glycylcycline antibiotics 4007: 3962:Quinupristin/dalfopristin 3920: 3892: 3864: 3726: 3715: 3669: 3615: 3606: 3580: 3494: 3479: 3459: 3398: 3281: 3266: 3257: 3230:inhibit protein synthesis 2698:10.1057/s41599-018-0181-x 2418:10.1016/j.jcf.2015.07.008 2152:10.1016/j.ccr.2011.10.015 2113:10.3109/10715769709097783 1890:10.1080/09546630510011810 1804:World Health Organization 1757:World Health Organization 1729:World Health Organization 1590:European Medicines Agency 1383:It is a third-generation 1350:broad-spectrum antibiotic 894:, vancomycin-susceptible 811:, vancomycin-susceptible 706: 681: 661: 639: 626: 593: 588: 569: 537: 517: 497: 477: 457: 437: 417: 392: 372: 349: 344: 327: 314: 304: 294: 286: 239: 234: 209: 194: 168: 138: 124: 106: 96: 42: 37: 28: 4089:Drugs developed by Wyeth 3481:Tetracycline antibiotics 2067:10.1073/pnas.93.24.14014 2007:Pharmacological Research 1182:Liver or kidney problems 1064:Clostridioides difficile 955:Streptococcus pneumoniae 828:Streptococcus agalactiae 783:It was removed from the 2685:Palgrave Communications 2189:STEM Fellowship Journal 1106:activity against acute 1044:Acinetobacter baumannii 939:Clostridium perfringens 911:Streptococcus anginosus 834:Streptococcus anginosus 752:Acinetobacter baumannii 729:tetracycline antibiotic 3103:10.1124/dmd.107.015735 1659:10.1592/phco.26.8.1099 1618:European Patent Office 1266:Tigecycline showed an 1029:Haemophilus influenzae 1016:methicillin-resistant 971:Legionella pneumophila 964:that does not produce 961:Haemophilus influenzae 902:methicillin-resistant 840:Streptococcus pyogenes 819:methicillin-resistant 3054:10.1515/hsz-2013-0292 2782:10.1128/AAC.38.9.2218 2650:10.1002/cpt1973145852 2571:10.1592/phco.28.7.895 2202:10.17975/sfj-2018-002 2101:Free Radical Research 1358:30S ribosomal subunit 1197:Resistance mechanisms 1160:Staphylococcus aureus 1146:Klebsiella pneumoniae 1082:Non-Antibacterial use 1073:Clostridium difficile 1034:Neisseria gonorrhoeae 1018:Staphylococcus aureus 998:, and to intravenous 928:Bacteroides uniformis 904:Staphylococcus aureus 897:Enterococcus faecalis 891:Klebsiella pneumoniae 852:Klebsiella pneumoniae 821:Staphylococcus aureus 814:Enterococcus faecalis 771:multi-drug resistance 746:Staphylococcus aureus 3671:Peptidyl transferase 3042:Biological Chemistry 3006:10.1128/AAC.01499-05 2831:10.1128/AAC.43.4.738 2246:10.1128/AAC.02099-19 1326:Lederle Laboratories 1250:pregnancy category D 1211:RND type efflux pump 933:Bacteroides vulgatus 917:Bacteroides fragilis 873:Enterobacter cloacae 867:Citrobacter freundii 858:Bacteroides fragilis 846:Enterobacter cloacae 776:It was given a U.S. 741:antibiotic resistant 733:bacterial infections 3300:Dihydrostreptomycin 2743:10.1021/jm00027a023 2615:10.1021/jo00804a025 2487:. 27 September 2013 2058:1996PNAS...9314014A 2052:(24): 14014–14019. 1428:Society and culture 1344:Mechanism of action 1307:Oral contraceptives 1122:Susceptibility data 1094:and suppression of 258:(Prescription only) 25: 4034:Never to phase III 3176:10.1093/jac/dkf196 2454:. 1 September 2010 1707:10.2146/ajhp050487 1257:acute pancreatitis 1203:Enterobacteriaceae 945:Peptostreptococcus 885:Klebsiella oxytoca 21: 4044: 4043: 4003: 4002: 3999: 3998: 3711: 3710: 3602: 3601: 3598: 3597: 3507:Chlortetracycline 3475: 3474: 2915:10.1345/aph.1H543 2870:(10): 1459–1462. 1701:(13): 1235–1243. 1348:Tigecycline is a 1292:Drug interactions 1285:black box warning 1283:The FDA issued a 1279:Black box warning 1273:black box warning 796:Antibacterial use 743:bacteria such as 718: 717: 652:Interactive image 539:CompTox Dashboard 278: 266: 253: 184: 151: 16:Chemical compound 4101: 4061: 4060: 4059: 4052: 3724: 3723: 3676: 3675: 3613: 3612: 3562:Rolitetracycline 3492: 3491: 3279: 3278: 3264: 3263: 3219: 3212: 3205: 3196: 3195: 3189: 3188: 3178: 3154: 3148: 3147: 3145: 3143: 3137:Medicines.org.uk 3129: 3123: 3122: 3097:(9): 1543–1553. 3085: 3074: 3073: 3037: 3028: 3027: 3017: 3000:(6): 2156–2166. 2985: 2979: 2978: 2968: 2944: 2935: 2934: 2894: 2888: 2887: 2859: 2853: 2852: 2842: 2810: 2804: 2803: 2793: 2776:(9): 2218–2220. 2761: 2755: 2754: 2725: 2719: 2718: 2700: 2676: 2670: 2669: 2633: 2627: 2626: 2598: 2592: 2591: 2573: 2549: 2543: 2542: 2506: 2497: 2496: 2494: 2492: 2473: 2464: 2463: 2461: 2459: 2440: 2431: 2430: 2420: 2396: 2390: 2389: 2379: 2347: 2341: 2340: 2311: 2305: 2302: 2296: 2295: 2293: 2291: 2282: 2274: 2268: 2267: 2257: 2221: 2215: 2214: 2204: 2180: 2174: 2173: 2163: 2131: 2125: 2124: 2096: 2090: 2089: 2079: 2069: 2037: 2031: 2030: 2002: 1993: 1992: 1956: 1945: 1944: 1916: 1910: 1909: 1873: 1867: 1866: 1864: 1862: 1851: 1832: 1831: 1819: 1800: 1794: 1793: 1773: 1753: 1747: 1746: 1744: 1725: 1719: 1718: 1690: 1679: 1678: 1653:(8): 1099–1110. 1642: 1629: 1628: 1626: 1624: 1610: 1604: 1603: 1601: 1599: 1581: 1572: 1571: 1569: 1567: 1552: 1525: 1524: 1522: 1520: 1505: 1499: 1498: 1496: 1494: 1479: 1407:Pharmacokinetics 1132:Escherichia coli 1108:myeloid leukemia 879:Escherichia coli 808:Escherichia coli 714: 713: 654: 634: 619: 613: 607: 601: 584: 573: 562: 561: 547: 545: 530: 510: 490: 470: 450: 430: 410: 400: 399: 385: 319: 276: 273: 264: 261: 251: 248: 226: 182: 179: 161: 150: 147: 134: 120: 91: 90: 87: 86: 83: 80: 77: 74: 71: 68: 65: 62: 59: 56: 53: 33: 26: 24: 20: 4109: 4108: 4104: 4103: 4102: 4100: 4099: 4098: 4069: 4068: 4067: 4057: 4055: 4047: 4045: 4040: 4039: 4024:Clinical trials 3995: 3981:Streptogramin B 3976:Streptogramin A 3916: 3888: 3860: 3707: 3688:Chloramphenicol 3665: 3619: 3594: 3576: 3557:Penimepicycline 3552:Oxytetracycline 3483: 3471: 3455: 3394: 3270: 3268:Aminoglycosides 3253: 3223: 3193: 3192: 3155: 3151: 3141: 3139: 3131: 3130: 3126: 3086: 3077: 3038: 3031: 2986: 2982: 2945: 2938: 2895: 2891: 2860: 2856: 2811: 2807: 2762: 2758: 2726: 2722: 2677: 2673: 2634: 2630: 2599: 2595: 2558:Pharmacotherapy 2550: 2546: 2507: 2500: 2490: 2488: 2475: 2474: 2467: 2457: 2455: 2442: 2441: 2434: 2397: 2393: 2348: 2344: 2312: 2308: 2303: 2299: 2289: 2287: 2280: 2276: 2275: 2271: 2222: 2218: 2181: 2177: 2132: 2128: 2097: 2093: 2038: 2034: 2003: 1996: 1957: 1948: 1917: 1913: 1874: 1870: 1860: 1858: 1853: 1852: 1835: 1828: 1801: 1797: 1782: 1754: 1750: 1726: 1722: 1691: 1682: 1647:Pharmacotherapy 1643: 1632: 1622: 1620: 1612: 1611: 1607: 1597: 1595: 1583: 1582: 1575: 1565: 1563: 1554: 1553: 1528: 1518: 1516: 1507: 1506: 1502: 1492: 1490: 1481: 1480: 1476: 1471: 1449: 1435: 1430: 1419:-acetyl-9-amino 1413:glucuronidation 1409: 1352:that acts as a 1346: 1319: 1294: 1281: 1261:cystic fibrosis 1245: 1227: 1199: 1184: 1124: 1084: 798: 793: 709: 707: 702: 699: 694: 689: 688: 677: 674: 669: 668: 657: 632: 622: 616: 610: 604: 565: 541: 533: 513: 493: 473: 453: 433: 413: 396: 388: 368: 365: 357: 356: 317: 310:Not metabolized 296:Protein binding 288:Pharmacokinetic 282: 230: 197: 190: 171: 164: 50: 46: 17: 12: 11: 5: 4107: 4097: 4096: 4091: 4086: 4081: 4066: 4065: 4042: 4041: 4038: 4037: 4036: 4035: 4032: 4021: 4015: 4009: 4008: 4005: 4004: 4001: 4000: 3997: 3996: 3994: 3993: 3983: 3978: 3973: 3959: 3945: 3926: 3924: 3922:Streptogramins 3918: 3917: 3915: 3914: 3909: 3904: 3898: 3896: 3890: 3889: 3887: 3886: 3881: 3876: 3870: 3868: 3862: 3861: 3859: 3858: 3853: 3848: 3843: 3841:Troleandomycin 3838: 3833: 3828: 3823: 3818: 3813: 3808: 3803: 3798: 3793: 3788: 3783: 3778: 3773: 3771:Flurithromycin 3768: 3763: 3758: 3756:Clarithromycin 3753: 3748: 3743: 3738: 3732: 3730: 3721: 3713: 3712: 3709: 3708: 3706: 3705: 3700: 3695: 3690: 3684: 3682: 3673: 3667: 3666: 3664: 3663: 3658: 3653: 3648: 3643: 3638: 3633: 3627: 3625: 3610: 3604: 3603: 3600: 3599: 3596: 3595: 3593: 3592: 3586: 3584: 3582:Glycylcyclines 3578: 3577: 3575: 3574: 3569: 3564: 3559: 3554: 3549: 3544: 3539: 3534: 3529: 3524: 3519: 3517:Demeclocycline 3514: 3509: 3504: 3498: 3496: 3489: 3477: 3476: 3473: 3472: 3470: 3469: 3463: 3461: 3457: 3456: 3454: 3453: 3448: 3442: 3441: 3440: 3439: 3434: 3429: 3424: 3419: 3408: 3406: 3402:Micromonospora 3396: 3395: 3393: 3392: 3390:Nourseothricin 3387: 3382: 3377: 3372: 3367: 3356: 3355: 3354: 3353: 3348: 3343: 3338: 3327: 3326: 3325: 3324: 3319: 3314: 3303: 3302: 3297: 3291: 3289: 3276: 3261: 3255: 3254: 3226:Antibacterials 3222: 3221: 3214: 3207: 3199: 3191: 3190: 3169:(5): 758–759. 3149: 3124: 3075: 3048:(5): 559–575. 3029: 2980: 2959:(4): 354–362. 2936: 2889: 2854: 2825:(4): 738–744. 2805: 2756: 2737:(1): 184–188. 2720: 2671: 2644:(5): 852–861. 2628: 2609:(5): 723–725. 2593: 2564:(7): 895–905. 2544: 2517:(4): 397–400. 2498: 2465: 2432: 2391: 2362:(1): 220–229. 2342: 2306: 2297: 2269: 2216: 2175: 2146:(5): 674–688. 2126: 2091: 2032: 1994: 1967:(2): 335–342. 1946: 1911: 1884:(4): 207–212. 1868: 1833: 1826: 1795: 1780: 1748: 1720: 1680: 1630: 1605: 1585:"Tygacil EPAR" 1573: 1562:. 20 July 2020 1526: 1515:. 21 June 2022 1500: 1473: 1472: 1470: 1467: 1466: 1465: 1462: 1459: 1456: 1453: 1448: 1445: 1440:United Kingdom 1434: 1431: 1429: 1426: 1408: 1405: 1391:which carry a 1389:glycylcyclines 1373:L. pneumophila 1362:aminoacyl-tRNA 1345: 1342: 1338:glycylcyclines 1334:glycylcyclines 1318: 1315: 1311: 1310: 1304: 1293: 1290: 1280: 1277: 1244: 1241: 1226: 1223: 1198: 1195: 1183: 1180: 1172: 1171: 1157: 1143: 1123: 1120: 1083: 1080: 1066:strains. Most 976: 975: 966:Beta-lactamase 950: 862: 797: 794: 792: 789: 716: 715: 704: 703: 701: 700: 697: 695: 692: 684: 683: 682: 679: 678: 676: 675: 672: 664: 663: 662: 659: 658: 656: 655: 647: 645: 637: 636: 630: 624: 623: 620: 614: 608: 602: 597: 591: 590: 586: 585: 575: 567: 566: 564: 563: 550: 548: 535: 534: 532: 531: 523: 521: 515: 514: 512: 511: 503: 501: 495: 494: 492: 491: 483: 481: 475: 474: 472: 471: 463: 461: 455: 454: 452: 451: 443: 441: 435: 434: 432: 431: 423: 421: 415: 414: 412: 411: 403: 401: 390: 389: 387: 386: 378: 376: 370: 369: 367: 366: 360: 352: 351: 350: 347: 346: 342: 341: 331: 325: 324: 321: 312: 311: 308: 302: 301: 298: 292: 291: 284: 283: 281: 280: 271: 259: 245: 243: 237: 236: 232: 231: 229: 228: 215: 213: 207: 206: 200: 198:administration 192: 191: 189: 188: 186: 176: 174: 166: 165: 163: 162: 144: 142: 136: 135: 128: 122: 121: 114: 104: 103: 100: 94: 93: 44: 40: 39: 35: 34: 15: 9: 6: 4: 3: 2: 4106: 4095: 4092: 4090: 4087: 4085: 4082: 4080: 4077: 4076: 4074: 4064: 4054: 4053: 4050: 4033: 4031: 4028: 4027: 4025: 4022: 4019: 4016: 4014: 4011: 4010: 4006: 3991: 3987: 3986:Virginiamycin 3984: 3982: 3979: 3977: 3974: 3971: 3967: 3963: 3960: 3957: 3953: 3949: 3946: 3943: 3939: 3935: 3931: 3930:Pristinamycin 3928: 3927: 3925: 3923: 3919: 3913: 3910: 3908: 3905: 3903: 3900: 3899: 3897: 3895: 3891: 3885: 3884:Solithromycin 3882: 3880: 3877: 3875: 3874:Telithromycin 3872: 3871: 3869: 3867: 3863: 3857: 3854: 3852: 3849: 3847: 3846:Tulathromycin 3844: 3842: 3839: 3837: 3834: 3832: 3829: 3827: 3826:Telithromycin 3824: 3822: 3819: 3817: 3816:Solithromycin 3814: 3812: 3811:Roxithromycin 3809: 3807: 3804: 3802: 3799: 3797: 3794: 3792: 3789: 3787: 3784: 3782: 3779: 3777: 3776:Gamithromycin 3774: 3772: 3769: 3767: 3764: 3762: 3761:Dirithromycin 3759: 3757: 3754: 3752: 3749: 3747: 3744: 3742: 3739: 3737: 3734: 3733: 3731: 3729: 3725: 3722: 3719: 3714: 3704: 3701: 3699: 3698:Thiamphenicol 3696: 3694: 3693:Azidamfenicol 3691: 3689: 3686: 3685: 3683: 3681: 3677: 3674: 3672: 3668: 3662: 3659: 3657: 3654: 3652: 3649: 3647: 3644: 3642: 3639: 3637: 3634: 3632: 3629: 3628: 3626: 3623: 3618: 3617:Oxazolidinone 3614: 3611: 3609: 3605: 3591: 3588: 3587: 3585: 3583: 3579: 3573: 3570: 3568: 3565: 3563: 3560: 3558: 3555: 3553: 3550: 3548: 3545: 3543: 3540: 3538: 3535: 3533: 3530: 3528: 3525: 3523: 3520: 3518: 3515: 3513: 3510: 3508: 3505: 3503: 3500: 3499: 3497: 3495:Tetracyclines 3493: 3490: 3487: 3482: 3478: 3468: 3465: 3464: 3462: 3458: 3452: 3449: 3447: 3444: 3443: 3438: 3435: 3433: 3430: 3428: 3425: 3423: 3420: 3418: 3415: 3414: 3413: 3410: 3409: 3407: 3404: 3403: 3397: 3391: 3388: 3386: 3383: 3381: 3378: 3376: 3373: 3371: 3370:Spectinomycin 3368: 3365: 3361: 3358: 3357: 3352: 3349: 3347: 3344: 3342: 3339: 3337: 3334: 3333: 3332: 3329: 3328: 3323: 3320: 3318: 3315: 3313: 3310: 3309: 3308: 3305: 3304: 3301: 3298: 3296: 3293: 3292: 3290: 3287: 3286: 3280: 3277: 3274: 3269: 3265: 3262: 3260: 3256: 3251: 3247: 3243: 3239: 3235: 3231: 3227: 3220: 3215: 3213: 3208: 3206: 3201: 3200: 3197: 3186: 3182: 3177: 3172: 3168: 3164: 3160: 3153: 3138: 3134: 3128: 3120: 3116: 3112: 3108: 3104: 3100: 3096: 3092: 3084: 3082: 3080: 3071: 3067: 3063: 3059: 3055: 3051: 3047: 3043: 3036: 3034: 3025: 3021: 3016: 3011: 3007: 3003: 2999: 2995: 2991: 2984: 2976: 2972: 2967: 2962: 2958: 2954: 2950: 2943: 2941: 2932: 2928: 2924: 2920: 2916: 2912: 2909:(6): 965–72. 2908: 2904: 2900: 2893: 2885: 2881: 2877: 2873: 2869: 2865: 2858: 2850: 2846: 2841: 2836: 2832: 2828: 2824: 2820: 2816: 2809: 2801: 2797: 2792: 2787: 2783: 2779: 2775: 2771: 2767: 2760: 2752: 2748: 2744: 2740: 2736: 2732: 2724: 2716: 2712: 2708: 2704: 2699: 2694: 2690: 2686: 2682: 2675: 2667: 2663: 2659: 2655: 2651: 2647: 2643: 2639: 2632: 2624: 2620: 2616: 2612: 2608: 2604: 2597: 2589: 2585: 2581: 2577: 2572: 2567: 2563: 2559: 2555: 2548: 2540: 2536: 2532: 2528: 2524: 2520: 2516: 2512: 2505: 2503: 2486: 2484: 2478: 2472: 2470: 2453: 2451: 2445: 2439: 2437: 2428: 2424: 2419: 2414: 2410: 2406: 2402: 2395: 2387: 2383: 2378: 2373: 2369: 2365: 2361: 2357: 2353: 2346: 2338: 2334: 2330: 2326: 2322: 2318: 2310: 2301: 2286: 2279: 2273: 2265: 2261: 2256: 2251: 2247: 2243: 2239: 2235: 2231: 2229: 2220: 2212: 2208: 2203: 2198: 2194: 2190: 2186: 2179: 2171: 2167: 2162: 2157: 2153: 2149: 2145: 2141: 2137: 2130: 2122: 2118: 2114: 2110: 2106: 2102: 2095: 2087: 2083: 2078: 2073: 2068: 2063: 2059: 2055: 2051: 2047: 2043: 2036: 2028: 2024: 2020: 2016: 2012: 2008: 2001: 1999: 1990: 1986: 1982: 1978: 1974: 1970: 1966: 1962: 1955: 1953: 1951: 1942: 1938: 1934: 1930: 1926: 1922: 1915: 1907: 1903: 1899: 1895: 1891: 1887: 1883: 1879: 1872: 1856: 1850: 1848: 1846: 1844: 1842: 1840: 1838: 1829: 1827:9789241515528 1823: 1818: 1813: 1809: 1805: 1799: 1791: 1787: 1783: 1781:9789241210300 1777: 1772: 1767: 1763: 1758: 1752: 1743: 1738: 1734: 1730: 1724: 1716: 1712: 1708: 1704: 1700: 1696: 1689: 1687: 1685: 1676: 1672: 1668: 1664: 1660: 1656: 1652: 1648: 1641: 1639: 1637: 1635: 1619: 1615: 1609: 1593: 1591: 1586: 1580: 1578: 1561: 1557: 1551: 1549: 1547: 1545: 1543: 1541: 1539: 1537: 1535: 1533: 1531: 1514: 1510: 1504: 1489:. 6 July 2020 1488: 1484: 1478: 1474: 1463: 1460: 1457: 1454: 1451: 1450: 1444: 1441: 1425: 1422: 1418: 1414: 1404: 1402: 1398: 1394: 1390: 1386: 1381: 1377: 1376: 1374: 1369: 1368: 1367:S. pneumoniae 1363: 1359: 1355: 1351: 1341: 1339: 1335: 1330: 1327: 1323: 1314: 1308: 1305: 1302: 1299: 1298: 1297: 1289: 1286: 1276: 1274: 1269: 1264: 1262: 1258: 1253: 1251: 1240: 1237: 1234: 1232: 1222: 1220: 1216: 1212: 1208: 1204: 1194: 1192: 1187: 1179: 1177: 1169: 1165: 1161: 1158: 1155: 1151: 1147: 1144: 1141: 1137: 1133: 1130: 1129: 1128: 1119: 1117: 1113: 1109: 1105: 1101: 1097: 1093: 1089: 1079: 1076: 1074: 1069: 1065: 1060: 1058: 1057: 1052: 1051: 1046: 1045: 1040: 1036: 1035: 1030: 1026: 1025: 1020: 1019: 1013: 1012:Gram-negative 1009: 1008:Gram-positive 1005: 1001: 997: 993: 989: 985: 984:Gram-negative 981: 980:Gram-positive 973: 972: 967: 963: 962: 957: 956: 951: 948: 946: 941: 940: 935: 934: 929: 925: 924: 919: 918: 913: 912: 907: 905: 899: 898: 893: 892: 887: 886: 881: 880: 875: 874: 869: 868: 863: 860: 859: 854: 853: 848: 847: 842: 841: 836: 835: 830: 829: 824: 822: 816: 815: 810: 809: 804: 803: 802: 788: 786: 781: 779: 774: 772: 768: 767:Gram-negative 764: 763:Gram-positive 760: 759: 754: 753: 748: 747: 742: 738: 737:glycylcycline 734: 730: 726: 722: 712: 705: 696: 691: 690: 687: 680: 671: 670: 667: 660: 653: 649: 648: 646: 643: 638: 631: 629: 625: 598: 596: 592: 587: 583: 579: 576: 574: 572:ECHA InfoCard 568: 560: 556: 555:DTXSID2048581 552: 551: 549: 540: 536: 529: 525: 524: 522: 520: 516: 509: 505: 504: 502: 500: 496: 489: 485: 484: 482: 480: 476: 469: 465: 464: 462: 460: 456: 449: 445: 444: 442: 440: 436: 429: 425: 424: 422: 420: 416: 409: 405: 404: 402: 395: 391: 384: 380: 379: 377: 375: 371: 363: 359: 358: 355: 348: 343: 340: 336: 332: 330: 326: 322: 320: 313: 309: 307: 303: 299: 297: 293: 289: 285: 279: Rx-only 272: 270: 260: 257: 247: 246: 244: 242: 238: 233: 225: 220: 217: 216: 214: 212: 208: 204: 201: 199: 193: 187: 178: 177: 175: 173: 167: 160: 155: 146: 145: 143: 141: 137: 133: 129: 127: 123: 119: 115: 113: 109: 105: 101: 99: 95: 89: 45: 43:Pronunciation 41: 38:Clinical data 36: 32: 27: 19: 4079:Carboxamides 3970:Quinupristin 3966:Dalfopristin 3894:Lincosamides 3831:Tildipirosin 3801:Oleandomycin 3766:Erythromycin 3736:Azithromycin 3589: 3572:Tetracycline 3547:Omadacycline 3532:Meclocycline 3522:Eravacycline 3512:Clomocycline 3427:Micronomicin 3400: 3375:Hygromycin B 3364:+loteprednol 3322:Ribostamycin 3295:Streptomycin 3285:Streptomyces 3283: 3166: 3162: 3152: 3140:. Retrieved 3136: 3127: 3094: 3090: 3045: 3041: 2997: 2993: 2983: 2956: 2952: 2906: 2902: 2892: 2867: 2863: 2857: 2822: 2818: 2808: 2773: 2769: 2759: 2734: 2730: 2723: 2688: 2684: 2674: 2641: 2637: 2631: 2606: 2602: 2596: 2561: 2557: 2547: 2514: 2510: 2491:26 September 2489:. Retrieved 2480: 2456:. Retrieved 2447: 2411:(1): e9-11. 2408: 2404: 2394: 2359: 2355: 2345: 2323:(1): 11–18. 2320: 2316: 2309: 2300: 2288:. Retrieved 2284: 2272: 2237: 2233: 2227: 2219: 2192: 2188: 2178: 2143: 2139: 2129: 2107:(1): 49–56. 2104: 2100: 2094: 2049: 2045: 2035: 2013:(1): 18–30. 2010: 2006: 1964: 1960: 1924: 1920: 1914: 1881: 1877: 1871: 1859:. Retrieved 1817:10665/312266 1807: 1798: 1771:10665/330668 1760: 1751: 1742:10665/325773 1732: 1723: 1698: 1694: 1650: 1646: 1623:29 September 1621:. Retrieved 1617: 1608: 1598:26 September 1596:. Retrieved 1588: 1566:26 September 1564:. Retrieved 1559: 1517:. Retrieved 1512: 1503: 1493:26 September 1491:. Retrieved 1486: 1477: 1436: 1416: 1410: 1396: 1392: 1385:tetracycline 1382: 1378: 1371: 1365: 1347: 1331: 1320: 1312: 1295: 1282: 1275:by the FDA. 1267: 1265: 1254: 1246: 1238: 1235: 1231:side effects 1228: 1225:Side effects 1218: 1214: 1206: 1200: 1191:hemodialysis 1188: 1185: 1175: 1173: 1167: 1163: 1159: 1153: 1149: 1145: 1139: 1135: 1131: 1125: 1112:glioblastoma 1103: 1099: 1096:angiogenesis 1085: 1077: 1072: 1068:C. difficile 1067: 1063: 1061: 1054: 1048: 1042: 1032: 1028: 1022: 1017: 977: 969: 959: 953: 943: 937: 931: 927: 921: 915: 909: 903: 895: 889: 883: 877: 871: 865: 856: 850: 844: 838: 832: 826: 820: 812: 806: 799: 791:Medical uses 782: 775: 756: 750: 744: 724: 720: 719: 708:   528:ChEMBL376140 508:CHEBI:149836 361: 316:Elimination 241:Legal status 235:Legal status 140:License data 18: 4020:from market 3956:Linopristin 3902:Clindamycin 3879:Cethromycin 3806:Rokitamycin 3791:Midecamycin 3786:Kitasamycin 3703:Florfenicol 3680:Amphenicols 3624:inhibitors) 3590:Tigecycline 3567:Sarecycline 3542:Minocycline 3537:Metacycline 3527:Lymecycline 3502:Doxycycline 3346:Bekanamycin 3317:Paromomycin 3275:inhibitors) 2195:(1): 5–11. 2140:Cancer Cell 1927:(1): 8–12. 1614:"EP2181330" 1447:Other names 1421:minocycline 1401:minocycline 1322:Minocycline 1243:Precautions 1215:Pseudomonas 1176:Pseudomonas 1092:proteolysis 1088:Minocycline 1075:infection. 1050:Pseudomonas 721:Tigecycline 635: g·mol 578:100.211.439 383:220620-09-7 345:Identifiers 203:Intravenous 159:Tigecycline 126:MedlinePlus 98:Trade names 23:Tigecycline 4073:Categories 3952:Flopristin 3912:Pirlimycin 3907:Lincomycin 3856:Tylvalosin 3836:Tilmicosin 3821:Spiramycin 3796:Miocamycin 3751:Carrimycin 3746:Carbomycin 3728:Macrolides 3651:Ranbezolid 3631:Eperezolid 3622:initiation 3451:Astromicin 3446:Verdamicin 3437:Isepamicin 3432:Plazomicin 3417:Netilmicin 3412:Gentamicin 3360:Tobramycin 3312:Framycetin 3273:initiation 2691:(1): 124. 2285:Toku-e.com 1861:31 October 1469:References 1152:g/mL — 16 1010:bacteria, 988:vancomycin 735:. It is a 640:3D model ( 628:Molar mass 468:70JE2N95KR 439:ChemSpider 374:CAS Number 354:IUPAC name 323:42.4 hours 306:Metabolism 4030:Phase III 4018:Withdrawn 3866:Ketolides 3781:Josamycin 3741:Boromycin 3661:Tedizolid 3656:Sutezolid 3646:Radezolid 3641:Posizolid 3636:Linezolid 3467:Butirosin 3422:Sisomicin 3385:Apramycin 3380:Totomycin 3351:Dibekacin 3341:Arbekacin 3331:Kanamycin 2707:2055-1045 2211:2369-0399 1790:0512-3054 1762:Children) 1487:Drugs.com 1268:increased 1205:(such as 1166:g/mL — 2 1138:g/mL — 4 1116:pythiosis 1021:(MRSA), 994:to treat 992:aztreonam 335:Bile duct 329:Excretion 318:half-life 196:Routes of 170:Pregnancy 118:Monograph 112:Drugs.com 4063:Medicine 3488:binding) 3399:-micin ( 3336:Amikacin 3307:Neomycin 3282:-mycin ( 3185:12407139 3142:13 March 3111:17537869 3070:12668198 3062:24497223 3024:16723578 2975:17359318 2923:17519296 2884:10360756 2849:10103174 2715:53086078 2666:30279473 2580:18576904 2539:36614422 2531:24597542 2458:13 March 2427:26282838 2386:15616299 2337:27256586 2290:13 March 2264:32015039 2228:In Vitro 2170:22094260 2027:23085382 1989:43407481 1981:25539800 1941:25982915 1906:28869637 1898:16249141 1857:. Pfizer 1806:(2019). 1759:(2019). 1731:(2019). 1715:16790575 1675:29714610 1667:16863487 1560:DailyMed 1519:30 March 1433:Approval 1301:Warfarin 1207:E. coli) 1134:: 0.015 1100:in vitro 1053:spp. or 1000:imipenem 711:(verify) 448:10482314 419:DrugBank 211:ATC code 172:category 154:DailyMed 3851:Tylosin 3119:5070076 3015:1479133 2931:5686856 2800:7811053 2751:8289194 2658:4199710 2623:5545572 2588:3474652 2255:7179303 2161:3221282 2121:9018471 2086:8943052 2054:Bibcode 1455:Tygacil 1452:GAR-936 1317:History 1148:: 0.06 1104:in vivo 1056:Proteus 758:E. coli 727:, is a 725:Tygacil 633:585.658 595:Formula 428:DB00560 408:5282044 394:PubChem 227:) 221: ( 219:J01AA12 185: D 156::  132:a614002 102:Tygacil 4049:Portal 4013:WHO-EM 3948:NXL103 3250:QJ01XQ 3183:  3117:  3109:  3068:  3060:  3022:  3012:  2973:  2929:  2921:  2882:  2847:  2837:  2798:  2791:284718 2788:  2749:  2713:  2705:  2664:  2656:  2621:  2586:  2578:  2537:  2529:  2425:  2384:  2377:538906 2374:  2335:  2262:  2252:  2209:  2168:  2158:  2119:  2084:  2074:  2025:  1987:  1979:  1939:  1904:  1896:  1824:  1788:  1778:  1713:  1673:  1665:  1037:(with 1031:, and 947:micros 942:, and 914:grp., 906:(MRSA) 855:, and 837:grp., 823:(MRSA) 755:, and 666:SMILES 519:ChEMBL 488:D01079 339:kidney 337:, 33% 300:71–89% 269:℞-only 267: 254: 152:  92: 3716:MLS ( 3460:other 3228:that 3115:S2CID 3066:S2CID 2927:S2CID 2840:89200 2711:S2CID 2662:S2CID 2584:S2CID 2535:S2CID 2485:(FDA) 2481:U.S. 2452:(FDA) 2448:U.S. 2281:(PDF) 2240:(4). 2077:19486 1985:S2CID 1902:S2CID 1671:S2CID 1592:(EMA) 686:InChI 642:JSmol 499:ChEBI 3486:tRNA 3246:J01G 3242:J01F 3238:J01B 3234:J01A 3181:PMID 3144:2017 3107:PMID 3058:PMID 3020:PMID 2971:PMID 2919:PMID 2880:PMID 2845:PMID 2796:PMID 2747:PMID 2703:ISSN 2654:PMID 2619:PMID 2576:PMID 2527:PMID 2493:2020 2460:2017 2423:PMID 2382:PMID 2333:PMID 2292:2017 2260:PMID 2207:ISSN 2166:PMID 2117:PMID 2082:PMID 2023:PMID 1977:PMID 1937:PMID 1894:PMID 1863:2015 1822:ISBN 1786:ISSN 1776:ISBN 1711:PMID 1663:PMID 1625:2017 1600:2020 1568:2020 1521:2024 1495:2020 1370:and 1219:rpsJ 1170:g/mL 1156:g/mL 1142:g/mL 1102:and 990:and 982:and 968:and 765:and 479:KEGG 459:UNII 333:59% 290:data 205:(IV) 108:AHFS 3942:IIB 3938:IIA 3608:50S 3259:30S 3171:doi 3099:doi 3050:doi 3046:395 3010:PMC 3002:doi 2961:doi 2911:doi 2872:doi 2835:PMC 2827:doi 2786:PMC 2778:doi 2739:doi 2693:doi 2646:doi 2611:doi 2566:doi 2519:doi 2413:doi 2372:PMC 2364:doi 2325:doi 2250:PMC 2242:doi 2197:doi 2156:PMC 2148:doi 2109:doi 2072:PMC 2062:doi 2015:doi 1969:doi 1929:doi 1886:doi 1812:hdl 1766:hdl 1737:hdl 1703:doi 1655:doi 1039:MIC 544:EPA 398:CID 224:WHO 4075:: 4026:: 3990:S1 3968:, 3954:, 3940:, 3936:, 3934:IA 3248:, 3244:, 3240:, 3236:, 3179:. 3167:50 3165:. 3161:. 3135:. 3113:. 3105:. 3095:35 3093:. 3078:^ 3064:. 3056:. 3044:. 3032:^ 3018:. 3008:. 2998:50 2996:. 2992:. 2969:. 2957:13 2955:. 2951:. 2939:^ 2925:. 2917:. 2907:41 2905:. 2901:. 2878:. 2866:. 2843:. 2833:. 2823:43 2821:. 2817:. 2794:. 2784:. 2774:38 2772:. 2768:. 2745:. 2735:37 2733:. 2709:. 2701:. 2687:. 2683:. 2660:. 2652:. 2642:14 2640:. 2617:. 2607:36 2605:. 2582:. 2574:. 2562:28 2560:. 2556:. 2533:. 2525:. 2515:12 2513:. 2501:^ 2479:. 2468:^ 2446:. 2435:^ 2421:. 2409:15 2407:. 2403:. 2380:. 2370:. 2360:49 2358:. 2354:. 2331:. 2321:48 2319:. 2283:. 2258:. 2248:. 2238:64 2236:. 2232:. 2205:. 2191:. 2187:. 2164:. 2154:. 2144:20 2142:. 2138:. 2115:. 2105:26 2103:. 2080:. 2070:. 2060:. 2050:93 2048:. 2044:. 2021:. 2011:67 2009:. 1997:^ 1983:. 1975:. 1965:14 1963:. 1949:^ 1935:. 1925:46 1923:. 1900:. 1892:. 1882:16 1880:. 1836:^ 1820:. 1784:. 1774:. 1709:. 1699:63 1697:. 1683:^ 1669:. 1661:. 1651:26 1649:. 1633:^ 1616:. 1587:. 1576:^ 1558:. 1529:^ 1511:. 1485:. 1263:. 1193:. 1178:. 1118:. 1027:, 958:, 936:, 930:, 926:, 920:, 908:, 900:, 888:, 882:, 876:, 870:, 849:, 843:, 831:, 825:, 817:, 773:. 749:, 609:39 603:29 275:EU 263:US 256:S4 250:AU 181:AU 149:US 82:iː 73:aɪ 58:aɪ 4051:: 3992:) 3988:( 3972:) 3964:( 3958:) 3950:( 3944:) 3932:( 3720:) 3620:( 3484:( 3405:) 3366:) 3362:( 3288:) 3271:( 3252:) 3232:( 3218:e 3211:t 3204:v 3187:. 3173:: 3146:. 3121:. 3101:: 3072:. 3052:: 3026:. 3004:: 2977:. 2963:: 2933:. 2913:: 2886:. 2874:: 2868:9 2851:. 2829:: 2802:. 2780:: 2753:. 2741:: 2717:. 2695:: 2689:4 2668:. 2648:: 2625:. 2613:: 2590:. 2568:: 2541:. 2521:: 2495:. 2462:. 2429:. 2415:: 2388:. 2366:: 2339:. 2327:: 2294:. 2266:. 2244:: 2226:" 2213:. 2199:: 2193:4 2172:. 2150:: 2123:. 2111:: 2088:. 2064:: 2056:: 2029:. 2017:: 1991:. 1971:: 1943:. 1931:: 1908:. 1888:: 1865:. 1830:. 1814:: 1768:: 1739:: 1717:. 1705:: 1677:. 1657:: 1627:. 1602:. 1570:. 1523:. 1497:. 1417:N 1397:N 1395:, 1393:N 1375:. 1168:μ 1164:μ 1154:μ 1150:μ 1140:μ 1136:μ 974:. 949:. 861:. 644:) 621:8 618:O 615:5 612:N 606:H 600:C 546:) 542:( 362:N 277:: 265:: 252:: 183:: 110:/ 88:/ 85:n 79:l 76:k 70:s 67:ˈ 64:ə 61:ɡ 55:t 52:ˌ 49:/

Index


/ˌtɡəˈskln/
Trade names
AHFS
Drugs.com
Monograph
MedlinePlus
a614002
License data
DailyMed
Tigecycline
Pregnancy
category

Routes of
administration

Intravenous
ATC code
J01AA12
WHO
Legal status
S4
℞-only
Pharmacokinetic
Protein binding
Metabolism
Elimination half-life
Excretion
Bile duct
kidney
IUPAC name
CAS Number
220620-09-7

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.